SCC-112, a novel cell cycle-regulated molecule, exhibits reduced expression in human renal carcinomas

Gene

Volumn 328, Issue 1-2, 2004, Pages 187-196

  Kumar, Deepak ^a   Sakabe, Isamu ^a   Patel, Sonal ^a   Zhang, Ying ^a   Ahmad, Imran ^b   Gehan, Edmund A ^a   Whiteside, Theresa L ^c   Kasid, Usha ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b NeoPharm Inc   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

cDNA and predicted amino acid sequences; Cell death; DAPI; FBS; Fetal bovine serum; G2 M phase; Phenylmethylsulphonyl fluoride; PMSF; RCC; Renal cell carcinoma; SCC 112; Subcellular localization; Tumor vs. normal tissue expression

Indexed keywords

AMINO ACID; CASPASE 3; COMPLEMENTARY DNA; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN; PROTEIN SCC 112; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL STRAIN COS1; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; METAPHASE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; DNA, COMPLEMENTARY; FEMALE; G2 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANSFECTION;

BOVINAE; STAPHYLOCOCCUS PHAGE 3A;

EID: 1542395654     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2003.12.013     Document Type: Article

References (31)

1. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
2. Armitage P., Berry G.et al. Statistical Methods in Medical Research. 3rd ed. 2001;Blackwell, Malden, MA.
3. Arribas R., Ribas M., Risques R.A.et al. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival. Clin. Cancer Res. 11:1999;3454-3459.
4. Bai C., Sen P., Hofmann K., Ma L., Goebl M., Harper J.W., Elledge S.J. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell. 86:1996;263-274.
5. Baylin S.B., Herman J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16:2000;168-174.
6. Brown, B., et al., 1996. The University of Texas M.D. Anderson Cancer Center, Department of Biomathematics.
7. Clifford S.C., Maher E.R. Von Hippel-Lindau disease: clinical and molecular perspectives. Adv. Cancer Res. 82:2001;85-105.
8. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68:1999;383-424.
9. Feng B.J., Huang W., Shugart Y.Y.et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat. Genet. 31:2002;395-399.
10. Geck P., Szelei J., Jimenez J., Sonnenschein C., Soto A.M. Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus. J. Steroid Biochem. Mol. Biol. 68:1999;41-50.
11. Green D.R., Knight R.A., Melino G., Finazzi-Agro' A., Orrenius S. Ten years of publication in cell death. Cell Death Differ. 11:2004;2-3.
12. Johnstone R.W., Ruefli A.A., Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108:2002;153-164.
13. Kirchhausen T. Adaptors for clathrin-mediated traffic. Annu. Rev. Cell Dev. Biol. 15:1999;705-732.
14. Kirchhausen T., Nathanson K.L., Matsui W.et al. Structural and functional division into two domains of the large (100-to 115-kDa) chains of the clathrin-associated protein complex AP-2. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2612-2616.
15. Kissil J.L., Cohen O., Raveh T., Kimchi A. Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-alpha-and Fas-induced cell death. EMBO J. 18:1999;353-362.
16. Kitamura Y., Shimizu K., Tanaka S., Ito K., Emi M. Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma. Clin. Cancer Res. 6:2000;1819-1825.
17. Kumar D., Whiteside T.L., Kasid U. Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein. J. Biol. Chem. 275:2000;2973-2978.
18. Lerman M.I., Minna J.D. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The international lung cancer chromosome 3p21.3 tumor suppressor gene consortium. Cancer Res. 60:2000;6116-6133.
19. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
20. Nakai K., Kanehisa M. A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics. 14:1992;897-911.
21. Ohara O., Nagase T., Ishikawa K.-I.et al. Construction and characterzation of human brain cDNA libraries suitable for analysis of cDNA clones encoding relatively large proteins. DNA Res. 4:1997;53-59.
22. Panizza S., Tanaka T., Hochwagen A., Eisenhaber F., Nasmyth K. Pds5 cooperates with cohesin in maintaining sister chromatid cohesion. Curr. Biol. 10:2000;1557-1564.
23. Patel S., Wang F.-H., Whiteside T.L., Kasid U. Constitutive modulation of Raf-1 protein kinase is associated with differential gene expression of several known and unknown genes. Mol. Med. 3:1997;674-685.
24. Reutzel D., Mende M., Naumann S., Storkel S., Brenner W., Zabel B., Decker J. Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization. Cytogenet. Cell Genet. 93:2001;221-227.
25. Schouten H.C., Sanger W.G., Weisenburger D.D., Armitage J.O. Chromosomal abnormalities in patients with non-cutaneous T-cell non-Hodgkin's lymphoma. The Nebraska lymphoma study group. Eur. J. Cancer. 26:1990;618-622.
26. Soengas M., Capodieci P., Polsky D.et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. 409:2001;207-211.
27. Stebbins C.E., Kaelin W.G. Jr., Pavletich N.P. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science. 284:1999;455-461.
28. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
29. van Heemst D., James F., Poggeler S., Berteaux-Lecellier V., Zickler D. Spo76p is a conserved chromosome morphogenesis protein that links the mitotic and meiotic programs. Cell. 98:1999;261-271.
30. van Heemst D., Kafer E., John T., Heyting C., van Aalderen M., Zickler D. BimD/SPO76 is at the interface of cell cycle progression, chromosome morphogenesis, and recombination. Proc. Natl. Acad. Sci. U. S. A. 98:2001;6267-6272.
31. Wu X., Hsu T.C., Annegers J.F., Amos C.I., Fueger J.J., Spitz M.R. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res. 55:1995;557-561.